Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

December 4, 2019

Primary Completion Date

November 17, 2020

Study Completion Date

February 23, 2021

Conditions
Décolleté Wrinkles
Interventions
DEVICE

MRZF111

MRZF111 kit consisting of one syringe of RADIESSE® Volume injectable implant, injection needles and additional components. Physiological saline solution (0.9% NaCl) is used to dilute Radiesse Volume by 1:2. Radiesse consists of calcium hydroxylapatite particles suspended in an aqueous-based gel carrier.

Trial Locations (9)

14467

Merz Investigational Site #0490362, Potsdam

20146

Merz Investigational Site #0490095, Hamburg

22609

Merz Investigational Site #0490345, Hamburg

34121

Merz Investigational Site #0490309, Kassel

42287

Merz Investigational Site #0490367, Wuppertal

48317

Merz Investigational Site #0490375, Drensteinfurt

65812

Merz Investigational Site #0490189, Bad Soden

80539

Merz Investigational Site #0490371, München

80636

Merz Investigational Site #0490372, München

Sponsors
All Listed Sponsors
collaborator

Merz Pharmaceuticals GmbH

INDUSTRY

lead

Merz Aesthetics GmbH

INDUSTRY

NCT04177212 - Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | Biotech Hunter | Biotech Hunter